指南与共识小儿泌尿与泌尿修复泌尿系感染

欧洲泌尿外科学会/欧洲小儿泌尿外科学会儿童膀胱输尿管反流指南更新与摘要

Update and Summary of the European Association of Urology/European Society of Paediatric Urology Paediatric Guidelines on Vesicoureteral Reflux in Children.
指南 / 共识 · Eur Urol · 2024-01-05

该指南为2023年EAU/ESPU儿童膀胱输尿管反流(VUR)指南更新,基于截至2022年3月的结构化文献复习,强调膀胱肠道功能障碍(BBD)的评估与治疗、选择性使用持续抗生素预防(CAP),并明确高热UTI伴高级别VUR的初始药物与手术指征。

要点

  • BBD在如厕训练的UTI患儿中常见,增加发热性UTI和核素扫描局灶性摄取缺损风险。
  • CAP并非所有VUR患者均需使用;实用做法是考虑用至BBD消失。
  • 高热UTI伴高级别VUR推荐初始药物治疗,手术保留用于CAP不依从、突破性发热UTI或长期随访持续症状性VUR。

核心结论

  • 2023年EAU/ESPU指南更新为儿童VUR的管理和诊断评估提供实用考虑。
  • 对VUR患儿,如存在BBD应予以治疗;CAP的实用做法是考虑给药至BBD缓解。

研究设计与样本

  • 欧洲泌尿外科学会(EAU)与欧洲小儿泌尿外科学会(ESPU)指南2023年更新,针对儿童VUR章节。
  • 对上次更新至2022年3月所有相关出版物进行结构化文献复习。

主要发现

  • BBD在如厕训练的UTI患儿中常见(伴或不伴原发性VUR),增加发热性UTI和核素扫描局灶性摄取缺损风险。
  • CAP可能并非每位VUR患者都需要。
  • 文献未提供VUR患者CAP疗程的可靠信息,实用做法是考虑CAP直至BBD消失。
  • 腹腔镜膀胱外与经膀胱镜输尿管再植术在缓解率和并发症率方面均为良好选择。
  • 膀胱外手术是机器人再植术最常用入路,变异和成功率范围广。

关键数值与推荐

  • 高热UTI伴高级别VUR的推荐包括初始药物治疗,手术保留用于CAP不依从、CAP期间突破性发热UTI、长期随访持续的症状性VUR。
  • CAP的实用做法是考虑给药至BBD缓解。

临床怎么用

  • 对VUR患儿,如存在BBD应予以治疗。
  • CAP的实用做法是考虑给药至BBD缓解。
  • 高热UTI伴高级别VUR可初始药物治疗,手术保留用于CAP不依从、突破性发热UTI或长期随访持续症状性VUR。

局限性

  • 关于VUR的规定性文献仍有限,证据水平普遍较低。
  • 文献未提供VUR患者CAP疗程的可靠信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: The prescriptive literature on vesicoureteral reflux (VUR) is still limited and thus the level of evidence is generally low. The aim of these guidelines is to provide a practical approach to the treatment of VUR that is based on risk analysis and selective indications for both diagnostic tests and interventions. We provide a 2023 update on the chapter on VUR in children from the European Association of Urology (EAU) and European Society for Paediatric Urology (ESPU) guidelines. METHODS: A structured literature review was performed for all relevant publications published from the last update up to March 2022. KEY FINDINGS AND LIMITATIONS: The most important updates are as follows. Bladder and bowel dysfunction (BBD) is common in toilet-trained children presenting with urinary tract infection (UTI) with or without primary VUR and increases the risk of febrile UTI and focal uptake defects on a radionuclide scan. Continuous antibiotic prophylaxis (CAP) may not be required in every VUR patient. Although the literature does not provide any reliable information on CAP duration in VUR patients, a practical approach would be to consider CAP until there is no further BBD. Recommendations for children with febrile UTI and high-grade VUR include initial medical treatment, with surgical care reserved for CAP noncompliance, breakthrough febrile UTIs despite CAP, and symptomatic VUR that persists during long-term follow-up. Comparison of laparoscopic extravesical versus transvesicoscopic ureteral reimplantation demonstrated that both are good option in terms of resolution and complication rates. Extravesical surgery is the most common approach used for robotic reimplantation, with a wide range of variations and success rates. CONCLUSIONS AND CLINICAL IMPLICATIONS: This summary of the updated 2023 EAU/ESPU guidelines provides practical considerations for the management and diagnostic evaluation of VUR in children. ADVANCING PRACTICE: For children with VUR, it is important to treat BBD if present. A practical approach regarding the duration of CAP is to consider administration until BBD resolution. PATIENT SUMMARY: We provide a summary and update of guidelines on the diagnosis and management of urinary reflux (where urine flows back up through the urinary tract) in children. Treatment of bladder and bowel dysfunction is critical, as this is common in toilet-trained children presenting with urinary tract infection.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Gnech M, 't Hoen L, Zachou A, et al. Update and Summary of the European Association of Urology/European Society of Paediatric Urology Paediatric Guidelines on Vesicoureteral Reflux in Children. Eur Urol. 2024. PMID: 38182493. doi:10.1016/j.eururo.2023.12.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。